LIVN LIVANOVA PLC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 14 analyst firms say about LIVANOVA PLC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
12 rated views · 14 analyst/firm records · 14 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Average target is not above the current price
- Russell 2000 · Safest consensus · 6MNot scored · Average target is not above the current price
Recent analyst activity · last 90 days
Our tracked history has 7 reports on LIVN from 6 analyst firms in the last 90 days (14 firms in the past year).
Comparing each firm's latest target with its previous one: 3 raised their price target, 1 left it unchanged and 1 has its first observed target in the past year.
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Latest observed target change: Baird raised its target from $95.00 (set 14 Jul 2026) to $111.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | David Rescott | Buy | 14 Jul 2026 | 95.00 USD |
| Barclays | Christopher Pasquale | Buy | 7 Oct 2026 | 105.00 USD |
| Freedom Capital | Unnamed analyst | Hold | 30 Jun 2026 | — |
| Freedom Capital Markets | Keith Hinton | Hold | 30 Jun 2026 | 75.00 USD |
| Goldman Sachs | David H Roman | Hold | 14 May 2026 | 65.00 USD |
| Jefferies | Matthew C Taylor | Buy | 6 Aug 2026 | 100.00 USD |
| KeyBanc Capital Markets | Brett Fishbin | Buy | 5 Aug 2026 | 93.00 USD |
| Mizuho | Anthony Petrone | Buy | 15 Jul 2026 | 95.00 USD |
| Needham | Mike Matson | Buy | 5 Aug 2026 | 93.00 USD |
| Piper Sandler | Adam Maeder | Buy | 2 Sep 2026 | 90.00 USD |
| Stifel | Unnamed analyst | — | 5 Aug 2026 | 85.00 USD |
| Weiss Ratings | Unnamed analyst | — | 27 Oct 2026 | — |
| Wolfe Research | Mike Polark | Buy | 6 Aug 2026 | 90.00 USD |
| Data feed RESEARCH | Research Team | Hold | 19 Aug 2026 | 82.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 04:43 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.